ViCentra
ViCentra is dedicated to revolutionizing diabetes management through innovative, user-friendly insulin pump systems. Founded in 2013 in Utrecht, Netherlands, the company develops and manufactures the Kaleido insulin pump, emphasizing simplicity, style, and personalization to help people with diabetes live life on their own terms. With a focus on customer experience, sustainability, and technological advancement, ViCentra aims to make a meaningful difference in the lives of those managing diabetes.
Industries
Nr. of Employees
medium (51-250)
Patents
Products
Wearable insulin patch pump system (reusable rechargeable)
A small, rechargeable patch pump system designed for wearable or pocket use with replaceable single‑use cartridges and infusion sets; includes handset and options for different tubing lengths and wearing styles. Device is intended for adult insulin delivery therapy.
Wearable insulin patch pump system (reusable rechargeable)
A small, rechargeable patch pump system designed for wearable or pocket use with replaceable single‑use cartridges and infusion sets; includes handset and options for different tubing lengths and wearing styles. Device is intended for adult insulin delivery therapy.
Services
Cloud integration providing 24/7 access to glucose and therapy data, web-based visualization and controlled sharing with healthcare professionals and caregivers.
End-user support via helpline, online knowledge center, and instructional videos to assist with device operation, troubleshooting and therapy education.
Cloud integration providing 24/7 access to glucose and therapy data, web-based visualization and controlled sharing with healthcare professionals and caregivers.
End-user support via helpline, online knowledge center, and instructional videos to assist with device operation, troubleshooting and therapy education.
Expertise Areas
- Insulin delivery device development
- Wearable medical device manufacturing
- Embedded medical device software
- Closed‑loop insulin delivery systems
Key Technologies
- Hybrid closed‑loop control algorithms
- Continuous glucose monitoring (CGM) integration
- Adaptive/self‑learning algorithms
- Embedded firmware for wearable devices
News & Updates
ViCentra secures CE Mark Certification for Kaleido Insulin Pump Under EU Medical Device Regulation
ViCentra announced that its Kaleido insulin pump has received CE mark certification, marking a significant milestone for the company's product in the European market.
Kaleido launches cutting-edge Hybrid Closed Loop system with Diabeloop and Dexcom for people with diabetes
ViCentra launched a new hybrid closed-loop system integrating Kaleido with Diabeloop and Dexcom G6, enhancing automated insulin delivery for people with diabetes.
Official opening of ViCentra’s new headquarters in Utrecht
ViCentra officially opened its new headquarters in Utrecht, Netherlands, marking a new chapter in its growth and development.
ViCentra closes EUR 65M (USD 74M) Series C funding to expand the footprint of Kaleido across Europe
The company secured significant Series C funding to support the expansion of Kaleido insulin pump across Europe.
ViCentra appoints two new medical and scientific advisors
The company announced the appointment of Dr. David Kerr and Dr. Fred Storms as new medical and scientific advisors.
Kaleido wins at the AVA Digital Awards 2019
Recognition for the redesign of Kaleido's website, awarded Bronze at the AVA Digital Awards 2019.
ViCentra secures CE Mark Certification for Kaleido Insulin Pump Under EU Medical Device Regulation
ViCentra announced that its Kaleido insulin pump has received CE mark certification, marking a significant milestone for the company's product in the European market.
Kaleido launches cutting-edge Hybrid Closed Loop system with Diabeloop and Dexcom for people with diabetes
ViCentra launched a new hybrid closed-loop system integrating Kaleido with Diabeloop and Dexcom G6, enhancing automated insulin delivery for people with diabetes.
Official opening of ViCentra’s new headquarters in Utrecht
ViCentra officially opened its new headquarters in Utrecht, Netherlands, marking a new chapter in its growth and development.
ViCentra closes EUR 65M (USD 74M) Series C funding to expand the footprint of Kaleido across Europe
The company secured significant Series C funding to support the expansion of Kaleido insulin pump across Europe.
ViCentra appoints two new medical and scientific advisors
The company announced the appointment of Dr. David Kerr and Dr. Fred Storms as new medical and scientific advisors.
Kaleido wins at the AVA Digital Awards 2019
Recognition for the redesign of Kaleido's website, awarded Bronze at the AVA Digital Awards 2019.